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Already 40 genes have been identified for autosomal-recessive nonsyndromic hearing impairment (arNSHI); however, manymore genes
are still to be identified. In a Dutch family segregating arNSHI, homozygosity mapping revealed a 2.4 Mb homozygous region on chro-
mosome 11 in p15.1-15.2, which partially overlapped with the previously described DFNB18 locus. However, no putative pathogenic
variants were found in USH1C, the gene mutated in DFNB18 hearing impairment. The homozygous region contained 12 additional
annotated genes including OTOG, the gene encoding otogelin, a component of the tectorial membrane. It is thought that otogelin
contributes to the stability and strength of this membrane through interaction or stabilization of its constituent fibers. The murine
orthologous genewas already known to cause hearing loss when defective. Analysis ofOTOG in theDutch family revealed a homozygous
1 bp deletion, c.5508delC, which leads to a shift in the reading frame and a premature stop codon, p.Ala1838ProfsX31. Further
screening of 60 unrelated probands from Spanish arNSHI families detected compound heterozygous OTOG mutations in one family,
c.6347C>T (p.Pro2116Leu) and c. 6559C>T (p.Arg2187X). The missense mutation p.Pro2116Leu affects a highly conserved residue
in the fourth von Willebrand factor type D domain of otogelin. The subjects with OTOG mutations have a moderate hearing impair-
ment, which can be associated with vestibular dysfunction. The flat to shallow ‘‘U’’ or slightly downsloping shaped audiograms closely
resembled audiograms of individuals with recessive mutations in the gene encoding a-tectorin, another component of the tectorial
membrane. This distinctive phenotype may represent a clue to orientate the molecular diagnosis.Autosomal-recessive nonsyndromic hearing impairment
(arNSHI, MIM 220700) is genetically extremely heteroge-
neous. So far more than 70 loci have been described and
for 41 of these also the mutated genes have been identified
(The Hereditary Hearing loss Homepage).1 Studies on mice
with spontaneous or chemically induced mutations have
not only significantly contributed to the discovery of deaf-
ness genes but also to the understanding of the molecular
mechanisms of hearing and the pathogenesis of deaf-
ness.2,3 The discovery of mutations in PTPRQ (MIM
603317) and LOXHD1 (MIM 613072) to underlie hearing
impairment nicely demonstrates the importance of mouse
mutants in this process.2,4–6
To identify novel deafness genes, we selected 102
familial cases from 44 families and 40 isolated cases with
putative arNSHI, almost exclusively of Dutch descent, for
homozygosity mapping. There were neither indications
for nongenetic causes of the hearing impairment in these
subjects nor for mutations in GJB2 (MIM 121011) or dele-
tions in GJB6 (MIM 604418). The study was approved
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The Americanthe tenets of the Declaration of Helsinki. Also, written
informed consent was obtained from all subjects or from
both parents in case of children. The approach of homozy-
gosity mapping in this cohort already led to the identifica-
tion of four novel deafness genes.6–9 Here we report on our
studies in a family of this cohort, W00-384, with four
affected sibs. The parents were not aware of any consan-
guinity. Genomic DNA isolated from peripheral blood
samples of all four affected subjects was used for high-
resolution SNP genotyping with Affymetrix Genechip
Genome-Wide Human Arrays 5.0. Data were analyzed
with the Genotyping Console software (Affymetrix) for
allele calling and the Partek Genomics Suite (Partek Incor-
porated) for calculation of the regions of homozygosity. In
total, five homozygous regions larger than 1 Mb were
found to be shared by all affected individuals, which varied
in size from 1.19 to 2.40 Mb. The largest of these shared
homozygous regions was located on chromosome 11 in
p15.1-15.2 (see Figure S1 available online). This region
was flanked by SNP_A-4222425 (rs10741672) and SNP_
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by genotyping small tandem repeat (STR) markers as
shown in Figure S2. Thirteen genes have been annotated
in this region that partially overlapped with the previously
described DFNB18 locus (MIM 602092). The other four
shared homozygous regions in family W00-384 neither
contained a known human or mouse deafness gene nor
did they overlap with a known deafness locus.
Mutations in USH1C (MIM 605242) have been described
as the cause of DFNB18 related hearing impairment.10–12
Sequence analysis of all exons and exon-intron boundaries
of this gene including the exons specifically expressed in
the inner ear, did not reveal any potentially pathogenic
variants. To determine whether compound heterozygous
mutations in genes known to be involved in recessive
and X-linked deafness might underlie the hearing impair-
ment in this family, SNP genotypes of the affected males
were compared for the corresponding regions. The four
affected individuals carried the same genotype for the
chromosomal region containing SMPX (MIM 300226)
and for the region containing STRC (MIM 606440).
Sequence analysis did not reveal any putatively causative
variants in these genes.
Within the 2.4 Mb homozygous region, OTOG (MIM
604487) was a second excellent candidate gene. It encodes
otogelin, a glycoprotein whose complementary DNA
(cDNA) was initially identified from a cochlea-derived sub-
stracted cDNA library.13 Otogelin is a noncollagenous
component of the acellular gelatinous structures that cover
the sensory epithelia of the inner ear, i.e., the tectorial
membrane (TM) in the cochlea, the otoconial membranes
in the utricle and saccule, and the cupulae that cover the
cristae ampullares of the semicircular canals in the vestib-
ular organ.13 Defects in the orthologous gene in mouse
result in hearing loss and severe imbalance.14,15 OTOG
is not fully annotated in the UCSC Genome Browser
(GRCh37/hg19). The UCSC gene uc001mnh.1 consists of
22 exons of which 21 are protein coding. However, the
NCBI gene database reports the larger transcript
XM_291816.8, which corresponds to the Ensemble tran-
script ENST00000399391 and encodes a protein of 2,925
amino acids. The orthologous gene in mouse encodes
a protein of 2,911 amino acids. With RT-PCR we were
able to detect transcripts with exons 26–27 and 54–55 in
addition to exons 14–15 in fetal inner ear (Table S1;
Figure S3). Sanger sequencing of all 55 exons represented
in XM_291816.8 was performed as described.9 Primer
sequences and PCR conditions are provided in Table S1.
A homozygous 1 bp deletion was identified in exon 35,
c.5508delC (reference sequence XM_291816.8), which is
predicted to cause a frameshift and a premature stop
codon, p.Ala1838ProfsX31 (Figure 1A). This variant was
found in homozygous state in the four affected sibs and
in heterozygous state in the parents. It was not found in
178 ethnically matched healthy controls by using restric-
tion digestion with NlaIV of the exon 35_2 amplicon.
The mutation removes an NlaIV restriction site. The
c.5508delC variant was also not reported in the 1000884 The American Journal of Human Genetics 91, 883–889, NovembGenomes Project. To exclude mutations in any of the addi-
tional 11 genes within the homozygous region (according
to UCSC Human Genome Database build hg19; Figure S1)
as the cause of the hearing impairment in this family, the
genes were analyzed by Sanger sequencing. No putative
causative variants were identified, only variants also
present in dbSNP as shown in Table S2.
In a parallel and independent approach, OTOG was
investigated in a cohort of 60 Spanish families with
arNSHI, which was moderate (24 families), severe (9 fami-
lies), or profound (27 families). All of them had at least
two affected siblings, and the presence of GJB2 muta-
tions or GJB6 deletions had been excluded by routine
testing. After approval of the study by the local medical
ethics committee, written informed consent was ob-
tained from all participants or their parents (in case
of children). Siblings and parents were genotyped for
STR-markers D11S902, D11S4138, and D11S4130, which
flank OTOG. Haplotype analysis revealed compatibility
with genetic linkage to these markers in seven families.
Sequencing of all 55 OTOG exons and exon/intron
boundaries in the index case of each pedigree revealed
five already known polymorphic variants and two novel
mutations: c.6347C>T (p.Pro2116Leu) in exon 37 and
c.6559C>T (p.Arg2187X) in exon 38 (reference sequence
XM_291816.8). These two mutations were in compound
heterozygous state in the two affected subjects of noncon-
sanguineous family S1778 (Figures 1C–1E). Parents were
heterozygous carriers, confirming that these mutations
were in trans in the affected subjects. These variants were
not found in 315 normal-hearing Spanish subjects with
sequence analysis of exons 37 and 38, and they were not
reported in the 1000 Genomes Project. The missense
mutation p.Pro2116Leu affects a highly conserved residue
(ConSeq score of 8, The ConSeq Server) in the fourth
von Willebrand factor type D domain of otogelin
(Figure 1F). Pathogenicity of this mutation is also sup-
ported by predictions from specialized software that
classified it as very likely damaging (score 0 in SIFT, score
0.97 in PolyPhen-2). A hypothetical pathogenic role of
the adjacent USH1C gene was excluded by sequencing all
its exons and exon-intron boundaries in one affected
subject of family S1778. Also, all other known arNSHI
genes were excluded in family S1778 by haplotype analysis
of flanking VNTR markers or by Sanger sequencing for
those genes that could not be excluded based on the
VNTR haplotypes. The latter set of genes included TMC1
(MIM 606706), OTOF (MIM 603681), CDH23 (MIM
605516), PCDH15 (MIM 605514), GRXCR1 (MIM
613283), TRIOBP (MIM 609761), MYO3A (MIM 606808),
WHRN (MIM 607928), ESRRB (MIM 602167), MARVELD2
(MIM 610572), PJVK (MIM 610219), LRTOMT (MIM
612414), BSND (MIM 606412), LOXHD1, TPRN (MIM
613354), and GJB3 (MIM 603324). No potentially patho-
genic variants were found.
To further study the involvement of OTOG in arNSHI we
screened a panel of 85 Dutch subjects with presumablyer 2, 2012
Figure 1. Mutation Analysis of OTOG
(A) Partial sequences are shown of OTOG exon 35 from an affected member and a parent of family W00-384 and a normal control. The
amino acids are indicated above the sequence. The c.5508delC variant found is predicted to result in a frameshift and premature stop
codon, p.Ala1838ProfsX31 (reference sequence XM_291816.8).
(B) Pedigree of family W00-384 and segregation of the c.5508delC variant.
(C) Partial sequences of OTOG exon 37 from a normal-hearing control and affected subject S1778 II.2, showing the c.6347C>T
(p.Pro2116Leu) substitution.
(D) Partial sequences of OTOG exon 38 from a normal-hearing control and affected subject S1778 II.2, showing the c.6559C>T
(p.Arg2187X) nonsense mutation.
(E) Pedigree of Spanish family S1778 and segregation analysis of the c.6347C>T and c.6559C>T mutations.
(F) Localization and conservation of the Pro-2116 residue. Above are shown domains of human otogelin. Red box, N-terminal signal
peptide; vWD, von Willebrand factor type D domain; C8, domain containing eight conserved cysteine residues; TIL, trypsin inhib-
itor-like domain; CT, cystine knot-like domain. The localization of the p.Pro2116Leu missense mutation is indicated by an arrow. Below
are shown alignment of diverse vertebrate otogelin (OTOG) and otogelin-like (OTOGL) amino acid sequences (accession numbers are
shown on the right). ConSeq conservation scores are shown by the color scale. Residue Pro-2116 (arrowhead), located in the fourth
von Willebrand factor type D domain, is highly conserved (score 8).arNSHI for presence of the c.5508delC variant. These
subjects were not preselected based on type or severity of
their hearing impairment. Mutations in GJB2 and GJB6
deletions were excluded in these individuals. No carriers
of the c.5508delC variant were found in this panel. Also,
screening of OTOG in 12 index patients of Dutch origin
with a similar audiogram as seen in subjects with OTOG
mutations did not reveal any putatively causative variants.
The same was true for probands of 13 families of Turkish
origin (1–3 affected subjects per family) in which theThe Americanaffected individuals were homozygous for STR-markers
D11S902 and D11S4138 that flank OTOG.
In mice, Otog is specifically expressed in inner ear.13 We
studied the expression of OTOG in human tissues by per-
forming quantitative PCR (qPCR) on cDNA from various
fetal and adult human tissues as described (Figure 2).9
Among the tested fetal tissues, the transcript level was
highest in inner ear, followed by kidney, lung, spleen,
thymus, and liver. Transcript levels were below detection
level in fetal heart, skeletal muscle, brain, colon, andJournal of Human Genetics 91, 883–889, November 2, 2012 885
Figure 2. OTOG Expression Profile in Human Tissues
Relative OTOG mRNA levels as determined by qPCR in fetal (A) and adult (B) tissues. Because this was performed for adult and fetal
tissues in two separate experiments, fetal inner ear was included in both to be able to compare the expression levels. The delta Ctmethod
was used to calculate the expression levels. To calculate the relative expression, we set the tissue with the lowest detectable expression
(Ct< 35) to 1. In the adult tissues, the expression in colonwas set to 1 and in fetal tissues the expression in kidney. RNAwas isolated from
inner ear of an embryo at 8 weeks gestation; the other fetal RNA samples were commercially available (all adult tissues from Stratagene;
fetal heart, brain, and kidney from Clontech, fetal skeletal muscle, liver, lung, spleen, thymus, colon, and stomach from Stratagene) and
derived from embryos at 20–21 weeks of gestation.stomach. In cDNA derived from tested adult tissues, OTOG
expression was detected with the highest level in retina
followed by testis and heart. These levels were lower than
in fetal inner ear, which was included in the same experi-
ment for comparison. Although OTOG transcription is
detected in several tissues, subjects with mutations in
OTOG only reported symptoms associated with inner ear
defects.
The four affected subjects of W00-384 all had a flat to
shallow U-shaped audiogram (Figure 3A). Three out of
these four affected individuals (II.1, II.2, and II.4) exhibited
a delayed speech development, which suggests a prelingual
onset of the hearing impairment. Subject II.1 was referred
for pure tone audiometry at the age of 7.5 years, and
a hearing loss of 40–45 dB was measured. Subsequently,
the three younger children were tested, which revealed
thresholds of 35–40 dB (subject II.2, 5.5 yrs), 40 dB (subject
II.3, 3.5 yrs), and 50 dB (subject II.4, 2 yrs). Representative
audiograms of all four hearing impaired subjects of W00-
384 are presented in Figure 3A. For subjects II.2 and II.4
of family W00-384, a delayed motor development was
reported, suggesting vestibular problems at young age.
Subject II.2 started to crawl and sit only at 12 months of
age, to stand at 14 months, and to walk at 18 months.
Subject II.4 had delayed milestones for crawling
(11months), rolling over (12months), sitting (12months),
standing (14 months), and walking (>24 months). Rotary
chair and caloric tests performed at the ages of 19 yrs, 17
yrs, 15 yrs, and 13 yrs for II.1, II.2, II.3, and II.4, respec-
tively, indeed demonstrated vestibular hyporeflexia in all
four affected subjects. A computed tomography (CT) scan
in subject II.2 revealed no inner ear abnormalities.
The two affected subjects of family S1778 had bilateral
hearing impairment, which was sensorineural, moderate,
and stable, as supported by serial audiograms at different
ages. The shape of the audiograms was slightly down-
sloping across all frequencies (Figure 3B). Although the
clinical diagnoses were established at ages 4 (subject II.1)
and 5 years (subject II.2), speech development was delayed886 The American Journal of Human Genetics 91, 883–889, Novembin both subjects, which suggests a prelingual onset. The
affected individuals had a normal motor development,
and they have not complained of dizziness or walking
instability during adulthood. A putative subclinical vestib-
ular dysfunction was investigated. Responses obtained
from oculomotor testing (saccade, optokinetics) and rota-
tory chair testing by videonystagmography were normal
in both subjects. However, bithermal caloric testing did
reveal a bilateral deficit.
Two mouse models have been described for OTOG, the
Otogtm1Prs mouse with targeted disruption of Otog by dele-
tion of the first three exons and the twister (twt) mouse
with a spontaneous recessive mutation leading to the
absence of Otog expression.14,15 Both mouse models have
a very similar phenotype with deafness and severe imbal-
ance.14,15 The hearing loss is bilateral and highly progres-
sive after birth, ranging from mild to profound.15 Otog/
pups start to show signs of vestibular dysfunction as early
as postnatal day (P)4.15
Unfortunately audiometric data before the age of 3.5 yrs
was missing for both families W00-384 and S1778. There-
fore, it is not clear whether, comparable to the Otogmouse
models, an early progressive hearing loss was preceding the
later stable phase of the hearing loss in the affected human
subjects. For all affected subjects of both families, the
hearing loss was stable since the first audiogram. The
delayed motor development in two of the affected subjects
from family W00-384 suggests early vestibular dysfunc-
tion. Vestibular function was affected in all four subjects
of W00-384 as confirmed by clear absence of asymmetry
of the directional nystagmus preponderance meausured
with rotational chair in all four subjects. On the contrary,
motor development in the two affected subjects of family
S1778 was normal and only bicaloric thermal testing
(performed in adulthood) revealed an anomaly suggestive
of a subclinical vestibular dysfunction. The differences
observed between humans and mice suggest that central
compensation may be more efficient in humans, as re-
ported for other audiovestibular conditions. The variabilityer 2, 2012
Figure 3. Audiometric Characterization
of OTOG Families
(A) Binaural mean air-conduction pure
tone threshold values of affected members
of family W00-384. These represent mean
values of audiograms at different ages for
each affected individual; II.1 (7.2–19.6
yrs), II.2 (5.4–17.2 yrs), II.3 (3.5–15.3 yrs),
and II.4 (3.9–13.8 yrs).
(B) Mean air-conduction pure tone
threshold values of family S1778. These
represent mean values of audiograms at
different ages for each affected individual;
5–30 years for subject II.1 and 6–24 years
for subject II.2. AD (aurio dextra) and AS
(aurio sinister) represent the right and left
ear, respectively.in vestibular dysfunction among the subjects in this
study might be related to their different OTOG genotypes
(homozygous truncating mutations versus heterozygous
truncating/nontruncating mutations) and/or to other
hypothetical modifier factors.
Otogelin is one of the three main noncollagenous
components of the TM besides a-tectorin (TECTA; MIM
602574) and b-tectorin (TECTB; MIM 602653). Also,
collagen types II, V, IX, and XI are main components of
the TM.16 In addition, a number of less abundant TM
proteins have been identified, e.g., CEACAM16. Moderate
hearing impairment with a U-shaped to flat audiogram is
the most common type of nonsyndromic hearing impair-
ment associated with defects in components of the TM.
This is seen for recessive TECTAmutations with one excep-
tion known,17 dominant CEACAM16 (MIM 614591) muta-
tions, dominant COL11A2 (MIM 120290) mutations, and
now also for recessive OTOG mutations.17–21 Recessive
mutations in STRC (MIM 606440), which encodes stereoci-
lin that functions in attaching the outer hair cell stereocilia
to the TM, also result in mild-to-moderate hearing impair-
ment.22,23 Exceptions are recessivemutations inCOL11A2.
However, this gene has a much broader expression pattern
in the inner ear than, for example, TECTA or OTOG.20, 24
Besides recessive mutations, also dominant mutations
occur in TECTA resulting in moderate mid-frequency or
high-frequency hearing impairment depending on the
protein domain affected by the mutation.25–29 Because
the severity of hearing loss associated with recessive
TECTA and OTOGmutations is very similar and the trans-
lated proteins are both part of the TM, OTOG might also
be a candidate gene for dominant hearing loss. So far, no
TECTB (MIM 602653) mutations have been described for
humans. Based on the presence of b-tectorin in the TM,
TECTB is a good candidate gene for moderate to
severe hearing loss with a flat to a shallow U-shaped
audiogram; Tectb/mice, however, display low-frequency
hearing loss.30
The precise function of otogelin in the gelatinous struc-
tures overlying the sensory epithelia of the inner ear is still
elusive. In mouse, Otog is expressed prenatally both in the
cochlea and the vestibular organ and our qPCR data indi-The Americancate an early expression in humans as well (week 8 of gesta-
tion).31 In mouse, expression of otogelin is higher in the
vestibular organ as compared to the cochlea.15,31 Otogelin
is not required for the formation of the acellular gelatinous
membranes of the inner ear because these are all formed in
complete absence of otogelin in mice. However, detach-
ment of the otoconial membranes and cupulae from the
sensory epithelia in the vestibule demonstrates that otoge-
lin is required for anchoring of these membranes to the
epithelia.15 This is not the case for the TM in the cochlea.
The precise localization of otogelin in the TM is still
unclear. Ultrastructural analysis of the TM of Otog/
mice demonstrated that all components of the TM are
formed including the type-A and type-B fibers. However,
because of the presence of some abnormal fibrilar or rod-
like structures in the TM of these Otog-deficient mice,
otogelin was proposed to be implicated in the interaction
or stabilization of the fibers in the TM.15 Multiple roles
for the TM have recently been identified using Tecta-defi-
cient or mutant mice.32–36 The TM ensures that outer
hair cells can effectively respond to basilar membrane
motion and that feedback is delivered with the appropriate
gain and timing required for amplification.33,35 A second
role for the TM is that it enables the motion of the basilar
membrane to optimally drive the inner hair cells at their
best frequencies.34 Similar detailed investigations of the
properties of the TM in Otog/ mice could provide more
insight into the function of otogelin in the TM.
In conclusion, we report the identification of mutations
in OTOG as a cause of moderate nonsyndromic hearing
loss. The shapes of the audiograms closely resemble those
associated with recessive TECTA mutations and can be
a clue to orientate molecular diagnostic testing. Recessive
TECTA mutations have not been reported to cause vestib-
ular symptoms, which are present in some subjects with
OTOG mutations. This phenotypic difference can be
a further clue to directed molecular diagnostic testing.Supplemental Data
Supplemental Data includes three figures and two tables and can
be found with this article online at http://www.cell.com/AJHG/.Journal of Human Genetics 91, 883–889, November 2, 2012 887
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